Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Zim Laboratories Ltd. Share Price
Day's Range
Day's Range
Low
₹95.02
High
₹103.00
Price Summary
| Previous Close | ₹98.16 |
|---|---|
| Day's Range | ₹95.02 - ₹103.00 |
| Open | ₹102.99 |
| 52 Week Range | ₹59.31 - ₹127.00 |
| Volume | 41,577 |
| Market Cap | ₹0.00 |
| Previous Close | ₹99.49 |
|---|---|
| Day's Range | ₹97.50 - ₹100.50 |
| Open | ₹98.00 |
| 52 Week Range | ₹59.72 - ₹126.95 |
| Volume | 1,145 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 40.81 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 76.43 |
| TTM EPS (₹) | 1.30 |
| P/E Ratio | 32.12 |
| Book Value(₹) | 1.84 |
| PAT Margin (%) | 3.21 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 8.29 |
| Trade Value ( ₹ in Lacs) | 1.14 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 76.43 |
| TTM EPS (₹) | 1.30 |
| P/E Ratio | 32.12 |
| Book Value(₹) | 1.84 |
| PAT Margin (%) | 3.21 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 8.29 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 963.3 | 3674.24 |
| Expenses | N/A | N/A |
| PBT | 57.04 | 236.42 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 40.01 | 172.46 |
About Zim Laboratories Ltd.
| Founded | 1984 |
|---|---|
| Managing Director | Anwar Siraj Daud |
| NSE Symbol | ZIMLAB |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,47,032.09 | 1,879.90 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,83,758.68 | 6,755.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,49,223.98 | 4,386.00 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,16,692.75 | 8,077.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,16,214.23 | 1,431.55 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,08,739.11 | 1,336.95 | 1,148.40 - 1,148.40 |
| Lupin Ltd. | 1,03,230.20 | 2,273.90 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 1,02,166.27 | 1,050.05 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 1,01,634.21 | 2,507.00 | 1,909.70 - 1,909.70 |
| Zydus Lifesciences Ltd. | 99,747.98 | 1,011.25 | 835.50 - 835.50 |
No Records Found
Latest News
Zim Laboratories informs about acquisition of equity shares of ZIMTAS
With reference to the above and pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), Zim Laboratories has informed that out of the approved investment amount of up to Rs 2.00 crore, the company has invested Rs 89.45 lakh which is 1,35,000 Australian Dollars in the equity shares of ZIMTAS. Post investment, the company holds 99.96% of the total share capital of ZIMTAS.
The above information is a part of company’s filings submitted to BSE.
Zim Laboratories informs about disclosure
Zim Laboratories informs about proceedings of EGM
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Zim Laboratories has informed that it enclosed proceedings of the 01st Extra Ordinary General Meeting of the Company for the F.Y. 2025-26 held on Monday, 16th February, 2026.
The above information is a part of company’s filings submitted to BSE.
Mangalam Drugs and Organics informs about newspaper advertisement
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mangalam Drugs and Organics has informed that it enclosed copies of newspaper advertisement published in Financial Express and Loksatta, both in which Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended March 31, 2026 have been published. The aforesaid results have been approved by the Board of Directors in its meeting held on Thursday, May 14, 2026.
The above information is a part of company’s filings submitted to BSE.
Star Imaging and Path Lab board to consider audited financial results
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Zim Laboratories Ltd. is ₹98.16 as of 2026-05-15.
The market capitalisation of Zim Laboratories Ltd. is ₹533.72 as of 2026-05-14.
The 1-year return of Zim Laboratories Ltd. is -1.85% as of 2026-05-15.
The P/E ratio of Zim Laboratories Ltd. is 32.12 as of 2026-05-15.
The 52-week high and low of Zim Laboratories Ltd. are ₹127.00 and ₹59.31, respectively, as of 2026-05-15.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
